Evaluation of Antifungal Activity Against Candida albicans Isolates From HIV-Positive Patients with Oral Candidiasis in a Major Referral Hospital, West Java, Indonesia

<i>C. albicans</i> predominated, with fluconazole and voriconazole showing high susceptibility, while nystatin and itraconazole demonstrated inhibition zones but could not be categorically interpreted due to the absence of established breakpoints. Routine species identification and susceptibility testing remain essential to guide therapy and monitor emerging resistance in immunocompromised populations, highlighting the need for further validation studies.